- Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain Fox Business
- BioNTech testing Pfizer COVID-19 vaccine against B.1.1.529 variant Business Insider
- Merck says its Covid antiviral treatment less effective than first thought Financial Times
- BioNTech says it will know vaccine's effectiveness against new variant in two weeks | TheHill The Hill
- With the Virus Still in Charge, Pfizer Can Be Flexible: Here's My Plan RealMoney
- View Full Coverage on Google News
from Top stories - Google News https://ift.tt/315y47e
No comments:
Post a Comment